Home » Medtronic Takes First Step Toward U.S. Sale of Artificial Pancreas
Medtronic Takes First Step Toward U.S. Sale of Artificial Pancreas
Medtronic has concluded a clinical trial that may yet make an artificial pancreas device with an automatic shut-off feature available to type 1 diabetics in the U.S. The results of the ASPIRE trial were published in the New England Journal of Medicine and presented at the American Diabetes Association meeting.
Reuters
Reuters
Upcoming Events
-
07May
-
14May
-
30May